Guanhe Pharmaceutical and Inmener's strategic cooperation

Company E News on August 28, Di'an diagnosed Shanghai Guanhe Pharmaceutical Technology Co., Ltd. and Inmener to reach a strategic cooperation, which will jointly provide early new drug research and development of quality, efficient, and innovative sequencing solutions.

According to the company's information, Shanghai Guanhe Pharmaceutical Technology Co., Ltd. was established in 2016 and was established by two top domestic medical service listed companies Dian diagnosed with Tiger Medicine. Guanhe Pharmaceutical is a one -stop CRO laboratory service solution supplier that meets the construction of international standards. Laboratory testing, biological analysis, logistics management, sample storage, clinical data management, and drug accompany diagnosis.

The company has passed the US CAP standard certification, NGSPI -level certification of the 4th member of the United States Sugin Hemorrhain Standard, and regularly participated in and passed the intercourse evaluation of the China Health and Health Commission and the Shanghai Inspection Center. As of 2021, the company has participated in many 40o drugs for testing in the Song Dynasty, and the specialties of the platform have passed the on -site audit of the CFDA National Bureau and the provincial bureaus. Tumor, cell immunotherapy, diabetes, hepatitis, cardiovascular disease and vaccine have accumulated rich laboratory technology and project management experience.

Smart bud data shows that Shanghai Guanhe Pharmaceutical Technology Co., Ltd. and its affiliated companies have cumulatively apply for 5 patents, of which 3 invention patents, accounting for 60%. By further analyzing its patented technology data, the company has a wealth of patent layout in the fields of quality control samples, blood dilution, driving teeth, cytokine and other fields.

- END -